AB Science announces
AB Science announces the signing of an exclusive licensing agreement with the University of Chicago to conduct research for the prevention and treatment of Covid-19
April 06, 2021 01:49 ET | AB Science
                                                                                                                                                                                                       ...
HSI is joined by 5G giants in the field of science and technology, and 5G new finance embraces blockchain
April 06, 2021 01:34 ET | Holy Shield Imperative ltd.
New York, NY , April 06, 2021 (GLOBE NEWSWIRE) -- The year 2020 is the year of 5G business. Under the global epidemic, 5G network technology, data center and other new construction plates have...
logo.gif
BGHL (EUR): NAV(s)
April 06, 2021 01:30 ET | BOUSSARD AND GAVAUDAN HOLDING LIMITED (EUR)
                                      BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following...
logo.gif
BGHL (GBP): NAV(s)
April 06, 2021 01:30 ET | BOUSSARD AND GAVAUDAN HOLDING LIMITED (GBP)
                                      BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following...
OSE.jpg
OSE Immunotherapeutics Announces First Peer-Reviewed Publication in "Science Advances" on OSE-230, its Novel Monoclonal Antibody Agonist Therapy Triggering Resolution of Chronic Inflammation
April 06, 2021 01:30 ET | OSE Immunotherapeutics
NANTES, France, April 06, 2021 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN: FR0012127173; Mnemo: OSE) announced the first peer-reviewed publication on OSE-230, a novel and innovative approach...
logo.jpg
Oxurion NV enters into a Capital Commitment of up to €30 Million with Negma Group
April 06, 2021 01:30 ET | Oxurion NV
Leuven, BE, Boston, MA, US – April 6, 2021 – 7.30 AM CET – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard-of-care back of the eye therapies,...
Valneva Reports Posi
Valneva Reports Positive Phase 1/2 Data for Its Inactivated, Adjuvanted COVID-19 Vaccine Candidate, VLA2001
April 06, 2021 01:00 ET | VALNEVA
  VLA2001 was well tolerated with no safety concerns identified In the high dose group :  IgG seroconversion rate of 100%  Neutralizing antibody titres at or above levels generally seen in...
beter bed.jpg
Beter Bed enables customers to sleep better and healthier with innovative technologies from Philips
April 06, 2021 01:00 ET | Beter Bed Holding NV
Starting this month, Beter Bed, the market leader in bedding in the Benelux, and Philips have teamed up to develop high-tech solutions that use highly sensitive sensors to measure and enhance sleep...
Santhera Commences C
Santhera Commences Convertible Bond Exchange Offer and Continues to Seek Votes on the Bondholders' Resolution
April 06, 2021 01:00 ET | Santhera Pharmaceuticals Holding AG
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO Pratteln, Switzerland, April 6, 2021 – Santhera Pharmaceuticals (SIX: SANN) gives an update on...
WISeKey Logo.png
World premiere set with luxury watch NFT auction
April 06, 2021 01:00 ET | Wisekey International Holding SA
Press releaseFor immediate distribution World premiere set with luxury watch NFT auction To date, the NFT auction has already received a bid of 25 ethers (~$50,000) for the digital twin of...